Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population

about

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.Certolizumab pegol in a heterogeneous population of patients with moderate-to-severe rheumatoid arthritis.

P2860

Q47836056-20C87F7B-C92C-4CAF-8904-208C86B2DAE3 Q55000881-7512CD52-0F22-4186-91A1-928CBE07CD17

P2860

Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population

Item

http://www.wikidata.org/entity/Q36279419

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Twenty-eight-week results from ...... heumatoid arthritis population

@ast

Twenty-eight-week results from ...... heumatoid arthritis population

@en

Twenty-eight-week results from ...... heumatoid arthritis population

@en-gb

type

Item

label

Twenty-eight-week results from ...... heumatoid arthritis population

@ast

Twenty-eight-week results from ...... heumatoid arthritis population

@en

Twenty-eight-week results from ...... heumatoid arthritis population

@en-gb

prefLabel

Twenty-eight-week results from ...... heumatoid arthritis population

@ast

Twenty-eight-week results from ...... heumatoid arthritis population

@en

Twenty-eight-week results from ...... heumatoid arthritis population

@en-gb

P1154

2-s2.0-84946829699

http://www.w3.org/2001/XMLSchema#string

P1433

Arthritis Research and Therapy

P1476

Twenty-eight-week results from ...... heumatoid arthritis population

@en

P2093

Benjamin Duncan

http://www.w3.org/2001/XMLSchema#string

Kristel Luijtens

http://www.w3.org/2001/XMLSchema#string

Michael E Weinblatt

http://www.w3.org/2001/XMLSchema#string

Owen Davies

http://www.w3.org/2001/XMLSchema#string

Roy Fleischmann

http://www.w3.org/2001/XMLSchema#string

Tom W J Huizinga

http://www.w3.org/2001/XMLSchema#string

P2860

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

Treating rheumatoid arthritis to target: recommendations of an international task force.

Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study.

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed.

High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis

Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.

P2888

s13075-015-0841-9

P304

325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13075-015-0841-9

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paul Emery

Désirée van der Heijde

Ronald van Vollenhoven

Maxime Dougados

Maurizio Cutolo

P5530

4764542

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283789700

http://www.w3.org/2001/XMLSchema#string

P6179

1007518265

http://www.w3.org/2001/XMLSchema#string

P6409

81210336

http://www.w3.org/2001/XMLSchema#string

P698

26568428

http://www.w3.org/2001/XMLSchema#string

P932

4644627

http://www.w3.org/2001/XMLSchema#string

P953

93875/